Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality

Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality

Abstract Aims Norepinephrine is recommended as a first‐line vasopressor agent in the haemodynamic stabilization of cardiogenic shock. The survival benefit of norepinephrine therapy has not been demonstrated in clinical practice, however. This study aimed to explore the relationship between norepinep...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Lu, Xue Wang, Yanxia Gao, Joseph Harold Walline, Shiyuan Yu, Zengzheng Ge, Mubing Qin, Huadong Zhu, Yi Li
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:ESC Heart Failure
Subjects:
Cardiogenic shock
Norepinephrine
Large observational database
Cohort study
Propensity score‐matching analysis
Online Access:https://doi.org/10.1002/ehf2.13893
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.13893

Similar Items